News
-
Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
-
Holcim to acquire OX Engineered Products
-
R&S Group informs about intended early redemption of warrants
-
Avolta celebrates duty-free contract win at Turkey’s new Çukurova International Airport
-
VAT Media Release ahead of Q3 2024 Results
-
Disclosure of Share Capital and Voting Rights as of September 30, 2024
-
Disclosure of trading in own shares from 30/09/2024 to 04/10/2024
-
Declaration of voting rights at the end of September 2024
-
MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
-
Disclosure of transactions in own shares on October 1 to October 4, 2024